Fig. 3: Projected economic burden of Parkinson’s disease in the U.S. by 2037 (billions in 2017 $).
From: Current and projected future economic burden of Parkinson’s disease in the U.S.
Bar chart of the projected economic burden of Parkinson’s disease in the U.S. by 2037. Authors’ projections by applying estimated 2017 direct medical cost using 2016 Optum claims data, 2015 Medicare Standard Analytical File 5% sample claims, and 2015 MCBS, and the indirect and non-medical costs estimated using data sources such as the CDC WONDER files, BLS earnings data, and responses from the PD Impact Survey, to projected future PD prevalence. Future PD prevalence was estimated by applying PD prevalence in 2017, estimated using 2011–2015 Medical Expenditure Panel Survey (MEPS), 2015 Medicare Current Beneficiary Survey (MCBS), and Census population projections for 2017, to future U.S. population projections from year 2018 to 2037.
